The primary goal of CLSI M45 is to provide essential guidance for antimicrobial susceptibility testing (AST) when resistance is a concern and the organism's susceptibility cannot be predicted by its identity alone.
The CLSI M45 document is relevant to:
Unlike M100, M45 does not always provide “S/I/R” (Susceptible/Intermediate/Resistant) breakpoints for every drug-organism pair due to limited clinical data. Instead, you may find: clsi document m45 pdf
Tables for diverse groups including Abiotrophia , Aerococcus , Campylobacter jejuni/coli , and Listeria monocytogenes Accessing the Standard Labs can access CLSI M45 through various channels: The primary goal of CLSI M45 is to
Unlike M100 (which provides “S/I/R” breakpoints for many drugs), M45 often provides or “provisional breakpoints” due to limited data. Labs must report results with interpretive comments. clsi document m45 pdf